• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病的分子病理生理学和抗银屑病治疗的分子靶点。

Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy.

机构信息

Department of Dermatology and Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

出版信息

Expert Rev Mol Med. 2009 Dec 14;11:e38. doi: 10.1017/S146239940900129X.

DOI:10.1017/S146239940900129X
PMID:20003607
Abstract

Psoriasis is a chronic inflammatory skin disease characterised by elevated red scaly plaques on specific body sites. Histologically, the plaques are defined by epidermal hyperplasia, epidermal and dermal infiltration by leukocytes, and changes in the dermal microvasculature. Differentiation and activation are disturbed in lesional psoriatic keratinocytes, and the pool of proliferating keratinocytes is increased, which is accompanied by enhanced production of proinflammatory cytokines, adhesion molecules and antimicrobial peptides. These changes in psoriatic keratinocytes are caused by altered expression of genes associated with epidermal differentiation, and by activation of signalling pathways involving signal transducer and activator of transcription 3 (STAT3), type I interferon (IFN) and mitogen-activated protein kinase (MAPK). The number of T cells, and myeloid and plasmacytoid dendritic cells (DCs) is markedly increased in psoriatic lesions. Myeloid DCs produce interleukin (IL)-23, tumour necrosis factor (TNF)-alpha and inducible nitric oxide synthase (iNOS), which are crucial cytokines in the pathogenesis of psoriasis. IL-23 stimulates the secretion of IL-22 by T helper 17 cells, and IL-22 induces epidermal hyperplasia. The crosstalk between keratinocytes and leukocytes via their proinflammatory cytokines creates the vicious circle of chronic skin inflammation seen in psoriasis. This suggests that optimal treatment of psoriasis needs to target pathogenic pathways in both leukocytes and keratinocytes.

摘要

银屑病是一种慢性炎症性皮肤病,其特征是在特定身体部位出现红色鳞屑斑块。组织学上,斑块由表皮过度增生、表皮和真皮白细胞浸润以及真皮微血管改变定义。病变银屑病角质形成细胞的分化和激活受到干扰,增殖角质形成细胞池增加,同时伴有促炎细胞因子、黏附分子和抗菌肽的产生增加。这些银屑病角质形成细胞的变化是由与表皮分化相关的基因表达改变以及涉及信号转导和转录激活因子 3(STAT3)、I 型干扰素(IFN)和丝裂原活化蛋白激酶(MAPK)的信号通路激活引起的。在银屑病病变中,T 细胞以及髓样和浆细胞样树突状细胞(DC)的数量明显增加。髓样 DC 产生白细胞介素(IL)-23、肿瘤坏死因子(TNF)-α和诱导型一氧化氮合酶(iNOS),它们是银屑病发病机制中的关键细胞因子。IL-23 刺激辅助性 T 细胞 17 细胞分泌 IL-22,IL-22 诱导表皮过度增生。角质形成细胞和白细胞通过其促炎细胞因子相互作用,形成银屑病慢性皮肤炎症的恶性循环。这表明,银屑病的最佳治疗需要针对白细胞和角质形成细胞中的致病途径。

相似文献

1
Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy.银屑病的分子病理生理学和抗银屑病治疗的分子靶点。
Expert Rev Mol Med. 2009 Dec 14;11:e38. doi: 10.1017/S146239940900129X.
2
Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.抗 TNF-α 治疗可优先抑制银屑病皮肤中 p38 丝裂原活化蛋白激酶调节细胞因子的 mRNA 表达。
Br J Dermatol. 2010 Dec;163(6):1194-204. doi: 10.1111/j.1365-2133.2010.10036.x.
3
Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.抗肿瘤坏死因子-α嵌合抗体(英夫利昔单抗)可抑制皮肤归巢性CD4+和CD8+ T淋巴细胞的活化,并损害树突状细胞功能。
Br J Dermatol. 2007 Aug;157(2):249-58. doi: 10.1111/j.1365-2133.2007.07945.x. Epub 2007 May 8.
4
Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris.银屑病基因组学:寻常型大斑块(西方型)和小斑块(亚洲型)银屑病促炎(1型)基因表达分析
Br J Dermatol. 2004 Apr;150(4):668-76. doi: 10.1111/j.0007-0963.2004.05891.x.
5
T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.寻常型银屑病患者皮肤损伤处衍生的T淋巴细胞表达一种新型细胞因子模式,该模式不同于1型辅助性T细胞和2型辅助性T细胞的细胞因子模式。
Eur J Immunol. 1994 Oct;24(10):2377-82. doi: 10.1002/eji.1830241018.
6
Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation.粒细胞集落刺激因子诱导的银屑病样皮炎在细胞因子表达异常和表皮活化方面与银屑病相似。
Exp Dermatol. 2004 Jun;13(6):340-6. doi: 10.1111/j.0906-6705.2004.00190.x.
7
Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis.炎症性树突状细胞及其产物的主要差异将特应性皮炎与银屑病区分开来。
J Allergy Clin Immunol. 2007 May;119(5):1210-7. doi: 10.1016/j.jaci.2007.03.006.
8
IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.白介素-21 促进 CD4+细胞向皮肤募集,并驱动 IFN-γ 依赖性表皮增生。
J Immunol. 2011 May 1;186(9):5435-42. doi: 10.4049/jimmunol.1003326. Epub 2011 Mar 25.
9
Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.特应性皮炎和银屑病患者的角质形成细胞在对T细胞衍生细胞因子的反应中表现出独特的趋化因子产生谱。
J Allergy Clin Immunol. 2001 May;107(5):871-7. doi: 10.1067/mai.2001.114707.
10
Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes.人表皮细胞中白细胞介素-10受体的展示及功能分析:在银屑病皮肤中表达降低,受白细胞介素-8下调,在正常培养的角质形成细胞中受抗银屑病糖皮质激素上调。
J Immunol. 1997 Dec 15;159(12):6291-7.

引用本文的文献

1
Diterpenoids and Triterpenoids From Frankincense Are Excellent Anti-psoriatic Agents: An Approach.乳香中的二萜类化合物和三萜类化合物是出色的抗银屑病药物:一种研究方法。
Front Chem. 2020 Jun 25;8:486. doi: 10.3389/fchem.2020.00486. eCollection 2020.
2
Current clinical issue of skin lesions in patients with inflammatory bowel disease.炎症性肠病患者皮肤病变的当前临床问题
Clin J Gastroenterol. 2019 Dec;12(6):501-510. doi: 10.1007/s12328-019-00958-y. Epub 2019 Mar 5.
3
Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.
全面、多模态表征咪喹莫特诱导的人类皮肤炎症模型用于药物开发。
Clin Transl Sci. 2018 Nov;11(6):607-615. doi: 10.1111/cts.12563. Epub 2018 Jul 3.
4
The Therapeutic Potential and Molecular Mechanism of Isoflavone Extract against Psoriasis.异黄酮提取物治疗银屑病的潜力及分子机制。
Sci Rep. 2018 Apr 20;8(1):6335. doi: 10.1038/s41598-018-24726-z.
5
Nonalcoholic fatty liver disease - A multisystem disease?非酒精性脂肪性肝病——一种多系统疾病?
World J Gastroenterol. 2016 Nov 21;22(43):9488-9505. doi: 10.3748/wjg.v22.i43.9488.
6
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines.使用托法替布抑制JAK治疗炎症性肠病:多种炎症细胞因子的汇聚点
Am J Physiol Gastrointest Liver Physiol. 2016 Feb 1;310(3):G155-62. doi: 10.1152/ajpgi.00311.2015. Epub 2015 Nov 25.
7
Non-alcoholic fatty liver disease and psoriasis: So far, so near.非酒精性脂肪性肝病与银屑病:咫尺天涯。
World J Hepatol. 2015 Mar 27;7(3):315-26. doi: 10.4254/wjh.v7.i3.315.
8
Design, synthesis and in vitro degradation of a novel co-drug for the treatment of psoriasis.新型银屑病治疗共药物的设计、合成及体外降解研究。
Pharmaceutics. 2013 Apr 17;5(2):232-45. doi: 10.3390/pharmaceutics5020232.
9
A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cells.一种穿膜肽适配体可抑制信号转导和转录激活因子3(STAT3)的功能,并抑制对STAT3有依赖的肿瘤细胞的生长。
JAKSTAT. 2012 Jan 1;1(1):44-54. doi: 10.4161/jkst.18947.
10
Targeting the redox balance in inflammatory skin conditions.针对炎症性皮肤病中的氧化还原平衡。
Int J Mol Sci. 2013 Apr 26;14(5):9126-67. doi: 10.3390/ijms14059126.